Key result
Tachypacing reduces fractional shortening ~42%, inducing severe systolic and mitochondrial dysfunction without oxidative stress.
Why the study?
While the knowledge of mitochondria has advanced in most cardiomyopathies, mitochondrial functions in tachycardiomyopathy have not been elucidated.
Absolute Event Rate: 21.9% vs 37.8%
p-value: p=<0.0001
Tachycardiomyopathy is characterized by a distinct pattern of mitochondrial dysfunction, including depletion of TCA cycle intermediates and altered redox balance, which diverges from other heart failure etiologies.
Distinct mitochondrial profile in tachycardiomyopathy suggests etiology-specific mechanisms; animal findings leave open human therapeutic translation.
Tachycardiomyopathy is characterised by reversible left ventricular dysfunction, provoked by rapid ventricular rate. While the knowledge of mitochondria advanced in most cardiomyopathies, mitochondrial functions await elucidation in tachycardiomyopathy. Pacemakers were implanted in 61 rabbits. Tachypacing was performed with 330 bpm for 10 days ( n = 11, early left ventricular dysfunction) or with up to 380 bpm over 30 days ( n = 24, tachycardiomyopathy, TCM). In n = 26, pacemakers remained inactive (SHAM). Left ventricular tissue was subjected to respirometry, metabolomics and acetylomics. Results were assessed for translational relevance using a human-based model: induced pluripotent stem cell derived cardiomyocytes underwent field stimulation for 7 days (TACH–iPSC–CM). TCM animals showed systolic dysfunction compared to SHAM (fractional shortening 37.8 ± 1.0% vs. 21.9 ± 1.2%, SHAM vs. TCM, p < 0.0001). Histology revealed cardiomyocyte hypertrophy (cross-sectional area 393.2 ± 14.5 µm 2 vs. 538.9 ± 23.8 µm 2 , p < 0.001) without fibrosis. Mitochondria were shifted to the intercalated discs and enlarged. Mitochondrial membrane potential remained stable in TCM. The metabolite profiles of ELVD and TCM were characterised by profound depletion of tricarboxylic acid cycle intermediates. Redox balance was shifted towards a more oxidised state (ratio of reduced to oxidised nicotinamide adenine dinucleotide 10.5 ± 2.1 vs. 4.0 ± 0.8, p < 0.01). The mitochondrial acetylome remained largely unchanged. Neither TCM nor TACH–iPSC–CM showed relevantly increased levels of reactive oxygen species. Oxidative phosphorylation capacity of TCM decreased modestly in skinned fibres (168.9 ± 11.2 vs. 124.6 ± 11.45 pmol·O 2 ·s −1 ·mg −1 tissue, p < 0.05), but it did not in isolated mitochondria. The pattern of mitochondrial dysfunctions detected in two models of tachycardiomyopathy diverges from previously published characteristic signs of other heart failure aetiologies.
No takes yet. Share an insight, caveat, or question.
Paulus et al. (2022) studied Tachycardiomyopathy (n=61). Tachypacing vs. Inactive pacemaker (SHAM) was evaluated on Fractional shortening (p=<0.0001). Tachypacing induced severe systolic dysfunction (fractional shortening 21.9% vs 37.8%, p<0.0001) and a distinct pattern of mitochondrial dysfunction without relevant oxidative stress or fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: